Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dexcom (DXCM) Interest Expenses (2016 - 2023)

Dexcom has reported Interest Expenses over the past 14 years, most recently at $5.9 million for Q2 2023.

  • Quarterly Interest Expenses rose 25.53% to $5.9 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Mar 2024, down 68.28% year-over-year, with the annual reading at $18.6 million for FY2022, 1.06% down from the prior year.
  • Interest Expenses was $5.9 million for Q2 2023 at Dexcom, up from $4.6 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $24.4 million in Q3 2020 and troughed at -$42.4 million in Q4 2020.
  • The 5-year median for Interest Expenses is $4.8 million (2021), against an average of $7.0 million.
  • Year-over-year, Interest Expenses surged 212.5% in 2019 and then tumbled 377.12% in 2020.
  • A 5-year view of Interest Expenses shows it stood at $15.3 million in 2019, then tumbled by 377.12% to -$42.4 million in 2020, then soared by 111.08% to $4.7 million in 2021, then changed by 0.0% to $4.7 million in 2022, then increased by 25.53% to $5.9 million in 2023.
  • Per Business Quant, the three most recent readings for DXCM's Interest Expenses are $5.9 million (Q2 2023), $4.6 million (Q1 2023), and $4.7 million (Q4 2022).